The SYNZULA brand, founded in 2015 (United States), from 13 sister brands and 2214 competing brands. SYNZULA is a brand of Lexicon Pharmaceuticals, listed on the stock exchange of New York. The sector of SYNZULA is Biotechnology.
Investment simulator :
Portfolio valuation
Lexicon Pharmaceuticals
(SYNZULA)
over 5 years*
USD 0.87